Journey Medical Corporation Sustainability Profile
Journey Medical Corporation, headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in dermatology and other therapeutic areas. Founded in 2016, the company has rapidly established itself through strategic partnerships and innovative product offerings, focusing on the development and commercialisation of prescription medications. With a diverse portfolio that includes unique formulations and delivery systems, Journey Medical aims to address unmet medical needs in skin health and beyond. The company’s commitment to quality and efficacy has positioned it as a trusted name among healthcare professionals. Notable achievements include a growing market presence and recognition for its contributions to dermatological care, underscoring its role as a leader in the industry.
DitchCarbon Score
How does Journey Medical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Journey Medical Corporation's score of 19 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Journey Medical Corporation's reported carbon emissions
Journey Medical Corporation, headquartered in the US, currently does not have specific carbon emissions data available for reporting. As a current subsidiary of Fortress Biotech, Inc., any emissions data would be inherited from this parent company. However, there are no documented reduction targets or climate pledges from Journey Medical Corporation itself. In the context of the industry, it is essential for companies to establish clear climate commitments and reduction initiatives to align with global sustainability goals. While Journey Medical Corporation has not publicly outlined specific targets or achievements, the broader pharmaceutical sector is increasingly focusing on reducing carbon footprints and enhancing environmental responsibility. As the company continues to develop its sustainability strategy, it may consider adopting industry-standard practices such as setting Science-Based Targets (SBTi) or participating in initiatives like the Carbon Disclosure Project (CDP) to improve transparency and accountability in its climate commitments.
How Carbon Intensive is Journey Medical Corporation's Industry?
How Carbon Intensive is Journey Medical Corporation's Location?
Journey Medical Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Journey Medical Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
